In this study, we show that the AlphaLISA assay is well suited for the quantification of VEGF-A in small sample volumes (just 10 μl of plasma or serum), enabling clinician scientists to obtain valuable data from blood samples of premature infants, where iatrogenic anaemia is an issue. This evidence concerns the gene VEGFA and anemia.